Characteristics of late-onset myasthenia gravis
- 5 April 2012
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 259 (10) , 2167-2171
Abstract
An increasing incidence of myasthenia gravis (MG) has been reported in the elderly, but the full clinical ramifications of late-onset myasthenia gravis (LOMG) remain unclear. We describe the clinical features of our cohort of patients with MG with an emphasis on an onset after the age of 50. This was a retrospective analysis of medical records of a cohort of patients followed in two tertiary neuromuscular clinics and comparison of early onset MG (EOMG) versus LOMG. There were 174 patients with a mean age of onset of 55.2 ± 19.1 years, and 44 % were women. Late onset of myasthenia gravis after age 50 was reported in 114 patients (66 %). Anti-AChR antibody titers were elevated in 78 % of patients (65 % with EOMG vs. 85 % with LOMG; p = 0.003), and frequency of elevated titers of anti-MuSK antibodies was similar in both groups (present in 38 % of all tested seronegative patients). Myasthenic crisis was equally common in generalized EOMG and LOMG (13 %). Ocular MG was more common in LOMG compared to EOMG (40 vs. 18 %, p = 0.021). Diabetes was more prevalent with LOMG (27 vs. 5 %; p = 0.0002). Overlapping clinical features of EOMG and LOMG are consistent with a continuous clinical spectrum of a single condition, with more frequent occurrence of seropositive and ocular MG with a late onset. A higher burden of comorbidities, such as diabetes mellitus, may warrant a modified approach to treatment of myasthenia in LOMG. However, overall disease severity may not be higher with aging. These observations have implications for design of MG clinical trials and outcomes studies.Keywords
This publication has 29 references indexed in Scilit:
- Maintenance of Immune Tolerance to a Neo-Self Acetylcholine Receptor Antigen with Aging: Implications for Late-Onset AutoimmunityThe Journal of Immunology, 2010
- Safety of intravenous immunoglobulin treatmentExpert Opinion on Drug Safety, 2010
- Plasma Exchange in Elderly PatientsTherapeutic Apheresis and Dialysis, 2010
- Immunotherapy in Elderly Transplant RecipientsDrugs & Aging, 2009
- Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitalsNeurology, 2009
- Autoimmune myasthenia gravis: emerging clinical and biological heterogeneityThe Lancet Neurology, 2009
- Myasthenia gravis: A study from IndiaNeurology India, 2008
- Clinical and serological study of myasthenia gravis in HuBei Province, ChinaJournal of Neurology, Neurosurgery & Psychiatry, 2006
- A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in JapanClinical Immunology, 2004
- Myasthenia Gravis and Elderly PeopleAge and Ageing, 1996